Multiplex H. pylori serology and risk of gastric cardia and noncardia adenocarcinomas

Cancer Research

Volumn 75, Issue 22, 2015, Pages 4876-4883

  Shakeri, Ramin ^a   Malekzadeh, Reza ^a   Nasrollahzadeh, Dariush ^a,b   Pawilta, Michael ^c   Murphy, Gwen ^d   Islami, Farhad ^a,e   Sotoudeh, Masoud ^a   Michel, Angelika ^c   Etemadi, Arash ^a,d   Waterboer, Tim ^c   Poustchi, Hossein ^f   Brennan, Paul ^g   Boffetta, Paolo ^h   Dawsey, Sanford M ^d   Kamangar, Farin ^a,i   Abnet, Christian C ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KAROLINSKA INSTITUTE   (Sweden)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d NATIONAL CANCER INSTITUTE   (United States)

^e AMERICAN CANCER SOCIETY   (United States)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ MORGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN G; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; CHAPERONIN 60; NITRATE REDUCTASE;

ADULT; ARTICLE; ASIAN; CANCER MORPHOLOGY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC CARDIA ADENOCARCINOMA; GASTRIC NONCARDIA ADENOCARCINOMA; HELICOBACTER INFECTION; HUMAN; INFECTION RATE; INTERMETHOD COMPARISON; IRAN; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEROLOGY; STOMACH ADENOCARCINOMA; TUMOR DIFFERENTIATION; ADENOCARCINOMA; AGED; BLOOD; CARDIA; COHORT ANALYSIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; RISK FACTOR; STOMACH TUMOR;

ADENOCARCINOMA; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CARDIA; CASE-CONTROL STUDIES; CHAPERONIN 60; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NITRATE REDUCTASE; RISK FACTORS; SEROLOGIC TESTS; STOMACH NEOPLASMS;

EID: 84955278228     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-0556     Document Type: Article

References (53)

1. El-Omar EM, Chow WH, Rabkin CS. Gastric cancer and H. pylori: host genetics open the way. Gastroenterology 2001;1214:1002-4.
2. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;11812:3030-44.
3. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1. 0. Cancer incidence and mortality worldwide. IARC Cancer Base No.11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.
4. Lochhead P, El-Omar EM. Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol 2007;212:281-97.
5. Webb PM, Law M, Varghese C, Forman D, Yuan JM, Yu M, et al. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;493:347-53.
6. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006;9820:1445-52.
7. Kamangar F, Qiao YL, Blaser MJ, Sun XD, Katki H, Fan JH, et al. Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer 2007;961:172-6.
8. McColl KE. Cancer of the gastric cardia. Best Pract Res Clin Gastroenterol 2006;204:687-96.
9. Blaser MJ, Berg DE. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001;1077:767-73.
10. Wroblewski LE, Peek RM Jr., Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 2010;234:713-39.
11. McColl KE, El-Omar E. How does H. pylori infection cause gastric cancer? Keio J Med 2002;51:53-6.
12. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995;8723:1777-80.
13. Ki MR, Hwang M, Kim AY, Lee EM, Lee EJ, Lee MM, et al. Role of vacuolating cytotoxin VacA and cytotoxin-associated antigen CagA of Helicobacter pylori in the progression of gastric cancer. Mol Cell Biochem 2014;396:23-32.
14. Atherton JC, Cao P, Peek RM Jr., Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995;27030:17771-7.
15. Michel A, Waterboer T, Kist M, Pawlita M. Helicobacter pylori multiplex serology. Helicobacter 2009;146:525-35.
16. Song H, Michel A, Nyren O, Ekstrom AM, Pawlita M, Ye W. A CagAindependent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology. Int J Cancer 2014; 13412:2942-50.
17. Epplein M, Zheng W, Xiang YB, PeekRMJr., Li H, Correa P, et al. Prospective study of Helicobacter pylori biomarkers for gastric cancer riskamong Chinese men. Cancer Epidemiol Biomarkers Prev 2012;2112:2185-92.
18. Gao L, Michel A, Weck MN, Arndt V, Pawlita M, Brenner H. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res 2009;6915:6164-70.
19. Murphy G, Freedman ND, Michel A, Fan JH, Taylor PR, Pawlita M, et al. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort. Int J Cancer 2015;137:1938-46.
20. Gao L, Weck MN, Michel A, Pawlita M, Brenner H. Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology. Cancer Res 2009;697:2973-80.
21. Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, et al. Opium; an emerging risk factor for gastric adenocarcinoma. Int J Cancer 2013;133:455-61.
22. Pourshams A, Khademi H, Malekshah AF, Islami F, Nouraei M, Sadjadi AR, et al. Cohort profile: the Golestan cohort study-a prospective study of oesophageal cancer in Northern Iran. Int J Epidemiol 2010;391:52-9.
23. Siev M, Yu X, Prados-Rosales R, Martiniuk FT, Casadevall A, Achkar JM. Correlation between serum and plasma antibody titers to mycobacterial antigens. Clin Vaccine Immunol 2011;181:173-5.
24. Pearce DC, Peach HG, Farish SJ. Helicobacter pylori antibody titres in serum, plasma and successively thawed specimens: implications for epidemiological and clinical studies. J Clin Pathol 1996;4912:1017-9.
25. Michel A, Pawlita M, Boeing H, Gissmann L, Waterboer T. Helicobacter pylori antibody patterns in Germany: a cross-sectional population study. Gut Pathogens 2014;6:10.
26. Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, et al. Multiplex human papillomavirus serology based on in situpurified glutathione s-transferase fusion proteins. Clin Chem 2005; 5110:1845-53.
27. Talebkhan Y, Mohammadi M, Khalili G, Sheykholeslami A, Rakhshani N, Mahboudi F, et al. Detection of Helicobacter pylori infection by imported IgG ELISA kits in comparison with Iranian home made kit. Govaresh 2006;112:120-5.
28. Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Abedi-Ardekani B, Khoshnia M, et al. Association of tooth loss and oral hygiene with risk of gastric adenocarcinoma. Cancer Prev Res (Phila) 2013; 65:477-82.
29. Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, et al. Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol 2009;384:978-88.
30. Kamangar F, Malekzadeh R, Dawsey SM, Saidi F. Esophageal cancer in Northeastern Iran: a review. Arch Iran Med 2007;101:70-82.
31. Roshandel G, Sadjadi A, Aarabi M, Keshtkar A, Sedaghat SM, Nouraie SM, et al. Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med 2012;154:196-200.
32. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu X-O, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010;429:764-7.
33. Helicobacter, Cancer CollaborativeG. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;493:347-53.
34. Hansen S, Melby KK, Aase S, Jellum E, Vollset SE. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer: a nested case-control study. Scand J Gastroenterol 1999;344:353-60.
35. Chow W-H, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;584:588-90.
36. Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H. Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control 2011;223:375-87.
37. Abnet CC, Qiao YL, Mark SD, Dong ZW, Taylor PR, Dawsey SM. Prospective study of tooth loss and incident esophageal and gastric cancers in China. Cancer Cause Control 2001;129:847-54.
38. Noto JM, Gaddy JA, Lee JY, Piazuelo MB, Friedman DB, Colvin DC, et al. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest 2013;1231:479-92.
39. Gaddy JA, Radin JN, Loh JT, Piazuelo MB, Kehl-Fie TE, Delgado AG, et al. The host protein calprotectin modulates the Helicobacter pylori cag type IV secretion system via zinc sequestration. PLoS Pathogens 2014;1010: e1004450.
40. Zhang Y-W, Eom S-Y, Yim D-H, Song Y-J, Yun H-Y, Park J-S, et al. Evaluation of the relationship between dietary factors, CagA-positive Helicobacter pylori infection, and RUNX3 promoter hypermethylation in gastric cancer tissue. World J Gastroenterol 2013;1911:1778.
41. Haley KP, Gaddy JA. Helicobacter pylori: genomic Insight into the Host-Pathogen Interaction. Int J Genomics 2015;2015:386905. doi: 10.1155/2015/386905.
42. Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut 2008;573:298-305.
43. Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut 2007;567: 918-25.
44. Yamaoka Y. Mechanismsof disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 2010;711:629-41.
45. Helgason H, Rafnar T, Olafsdottir HS, Jonasson JG, Sigurdsson A, Stacey SN, et al. Loss-of-function variants in ATM confer risk of gastric cancer. Nat Genet 2015;47:906-10.
46. Lin Z, Madan D, Rye HS. GroEL stimulates protein folding through forced unfolding. Nat Struct Mol Biol 2008;153:303-11.
47. Lin Z, Rye HS. GroEL-mediated protein folding: making the impossible, possible. Crit Rev Biochem Mol Biol 2006;414:211-39.
48. Yamaguchi H, Osaki T, Kurihara N, Taguchi H, Hanawa T, Yamamoto T, et al. Heat-shock protein 60 homologue of Helicobacter pylori is associated with adhesion of H. pylori to human gastric epithelial cells. JMed Microbiol 1997;4610:825-31.
49. Takenaka R, Yokota K, Ayada K, Mizuno M, Zhao Y, Fujinami Y, et al. Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells. Microbiology 2004;15012:3913-22.
50. Wang G, Hong Y, Olczak A, Maier SE, Maier RJ. Dual roles of Helicobacter pylori NapA in inducing and combating oxidative stress. Infect Immun 2006;7412:6839-46.
51. Proença-Modena JL, Acrani GO, Brocchi M. Helicobacter pylori: phenotypes, genotypes and virulence genes. Fut Microbiol 2009;42: 223-40.
52. Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N, et al. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 1998;423:338-43.
53. Shakeri R, Kamangar F, Nasrollahzadeh D, Nouraie M, Khademi H, Etemadi A, et al. Is opium a real risk factor for esophageal cancer or just a methodological artifact? Hospital and neighborhood controls in casecontrol studies. PLoS One 2012;73:e32711.